Accès direct au contenu


Version française > Publications > Publications 2015

Publications 2015


MI MIOT C, BEAUMONT E, DULUC D, , LE GUILLOU H, PREISSER L, GARO E, BLANCHARD S,  HUBERT-FOUCHARD I, CREMINON C, LAMOURETTE P, FREMAUX I, CALES P, LUNEL-FABIANI F, BOURSIER J, BRAUM O, FICKENSCHER H, ROINGEARD P, DELNESTE Y, JEANNIN P. Il-26 is overexpressed in chronically hcv-infected patients and enhances trail-mediated cytotoxicity and interferon production by human nk cells. Gut, 2015, 64 : 1466-1475.

BLANCHARD E, ROINGEARD P. Virus-induced double-membrane vesicles. Cell Microbiol, 2015, 17, 45-50.

SOULIE C, DESCAMPS D, GRUDE M, SCHNEIDER V, TRABAUD MA, MORAND-JOUBERT L, DELAUGERRE C, MONTES B, BARIN F, FERRE V, RAYMOND S, JEULIN H, ALLOUI C, YERLY S, PALLIER C, REIGADAS S, SIGNORI-SCHMUCK A, GUIGON A, FAFI-KREMER S, HAÏM-BOUKOBZA S, MIRAND A, MAILLARD A, VALLET S, ROUSSEL C, ASSOUMOU L, CALVEZ V, FLANDRE P, MARCELIN AG.  Antiretroviral-naive and -treated hiv-1 patients can harbour more resistant viruses in csf than in plasma. J Antimicrob Chemother, 2015, 70 : 566-572

ROUET F, DELEPLANCQUE L, BIVIGOU-MBOUMBA B, SICA J, MOUINGA-ONDEME A, LIEGEOIS F, GOUDEAU A, DUBOIS F, GAUDY-GRAFFIN C. usefulness of a fourth generation elisa assay for the reliable identification of hcv infection in hiv-positive adults from gabon, central africa. Plos One 2015 ; E0116975.

BEAUMONT E, ROINGEARD P. Chimeric hbv-hcv subviral envelope particles induce efficient anti-hcv antibody production in animals pre-immunized with hbv vaccine. Vaccine, 2015, 33 :973-976.

MOREL A, PASSOT C, ARNOULT C, DUMANS A, BEAUMONT E, GOUILLEUX-GRUART V, ROINGEARD P, BLANCHARD E. The neonatal fc receptor (fcrn) does not modulate hepatitis c virus neutralization. J Gen Virol, 2015, 96 : 1062-1066.

FOURATI S, CHARPENTIER C, AMIEL C, MORAND-JOUBERT L, REIGADAS S, TRABAUD MA, DELAUGERRE C, NICOT F, RODALLEC A, MAILLARD A, MIRAND A, JEULIN H, MONTES B, BARIN F, BETTINGER D, LE GUILLOU-GUILLEMETTE H, VALLET S, SIGNORI-SCHMUCK A, DESCAMPS D, CALVEZ V, FLANDRE P, MARCELIN AG. Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a french national study of raltegravir-experienced hiv-1-infected patients. J Antimicrob Chemother, 2015, 70 : 1507-1512.

FOGERON ML, PAUL D, JIRASKO V, MONTSERRET R, LACABANNE D, MOLLE J, BADILLO A, BOUKADIDA C, GEORGAULT S, ROINGEARD P, MARTIN A, BARTENSCHLAGER R, PENIN F, BÖCKMANN A. Functional expression, characterization and membrane reconstitution of hepatitis c virus non-structural protein 2. Protein Expr Purif, 2015, 116 : 1-6.

GAUTHERET-DEJEAN A, BOCOBZA J, BRUNET S, DAMOND F, PLANTIER JC, BARIN F. Performance of rapid tests for discrimination between hiv-1 and/or hiv-2 infections. J Med Virol, 2015, IN PRESS

LARRAT S, VALLET S, DAVID-TCHOUDA S, CAPOROSSI A, MARGIER J, RAMIERE C, SCHOLTES C, HAÏM-BOUKOBZA S, ROQUE-AFONSO AM, BESSE B, ANDRE-GARNIER E, MOHAMED S, HALFON P, PIVERT A, LEGUILLOU-GUILLEMETTE H, ABRAVANEL F, GUIVARCH M, MACKIEWICZ V, LADA O, MOUREZ T, PLANTIER JC, BAAZIA Y, ALAIN S, HANTZ S, THIBAULT V, GAUDY-GRAFFIN C, BOUVET D, MIRAND A, HENQUELL C, GOZLAN J, LAGATHU G, PRONIER C, VELAY A, SCHVOERER E, TRIMOULET P, FLEURY H, BOUVIER-ALIAS M, BROCHOT E, DUVERLIE G, MAYLIN S, GOURIOU S, PAWLOTSKY JM, MORAND P. Naturally occurring resistance-associated variants of hepatitis c virus protease inhibitors in poor responders to pegylated interferon-ribavirin. J Clin Microbiol, 2015, 53 : 2195-2202.

AOUDJEHANE L, BISCH G, SCATTON O, C GRANIER, GASTON J, HOUSSET C, ROINGEARD P, COSSET FL, PERDIGAO F, BALLADUR P, WAKITA T, CALMUS Y, CONTI F. Infection of human liver myofibroblasts by hepatitis c virus : a direct mechanism of liver fibrosis in hepatitis c. Plos One, 2015, 10 : E0134141.

LE GUILLOU-GUILLEMETTE H, DUCANCELLE A, BERTRAIS S, LEMAIRE C, PIVERT A, VEILLON P, BOUTHRY E, ALAIN S, THIBAULT V, ABRAVANEL F, ROSENBERG AR, HENQUELL C, ANDRE-GARNIER E, PETSARIS O, VALLET S, BOUR JB, BAAZIA Y, TRIMOULET P, ANDRE P, GAUDY-GRAFFIN C, BETTINGER D, LARRAT S, SIGNORI-SCHMUCK A, SAOUDIN H, POZZETTO B, LAGATHU G, MINJOLLE-CHA S, STOLL-KELLER F, PAWLOTSKY JM, IZOPET J, PAYAN C, LUNEL-FABIANI F. Identification of a duplicated v3 domain in ns5a associated with cirrhosis and hepatocellular carcinoma in hcv-1b patients. J Clin Virol, 2015, 69:203-209.

ROBINEAU O, FRANGE P, BARIN F, CAZEIN F, GIRARD PM, CHAIX ML, KREPLAK G, BOELLE PY, MORAND-JOUBERT L. Combining the estimated date of hiv infection with a phylogenetic cluster study to better understand hiv spread: application in a paris neighbourhood. Plos One, 2015, 10 : E013536.

ESTIENNE L, BLANCHARD E, BOYER A, DESVIGNES V, GAILLARD J, MEUNIER JC, ROINGEARD P, HOURIOUX C. The replacement of 10 non-conserved residues in the core protein of jfh-1 hepatitis c virus improves its assembly and secretion. Plos One, 2015, 10 : E0137182.

  • Facebook
  • twitter
  • google
  • imprimer
  • version PDF
  • Envoyer cette page

English version 


Contact 


Inserm - U966 MAVIVH
10 boulevard Tonnellé - BP 3223
37032 Tours Cedex 1 - France
Tél. : 33 (2) 47 36 61 27
Fax : 33 (2) 47 36 61 26

Secrétariat :
E-mail : angelique.masse@univ-tours.fr

Directeur : Philippe ROINGEARD

E-mail : roingeard@med.univ-tours.fr

Directeur adjoint : Francis BARIN

E-mail : fbarin@med.univ-tours.fr

 

Retour au site institutionnel